Xolair Enhances Asthma Treatment

This is a Xolair news story, published by The Atlantic, that relates primarily to Tami McGraw news.

Xolair news

For more Xolair news, you can click here:

more Xolair news

Tami McGraw news

For more Tami McGraw news, you can click here:

more Tami McGraw news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

The Atlantic news

For more news from The Atlantic, you can click here:

more news from The Atlantic

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Xolair

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest allergy news, asthma news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

allergy patients

The Atlantic

•

A Food-Allergy Fix Hiding in Plain Sight

Summary

Nutrition label

81% Informative

Tami McGraw used to be so allergic to red meat that even fumes from cooking might send her into anaphylactic shock.

Xolair works by intercepting immune molecules called IgE , known to be a trigger in allergic reactions.

The drug is finally available to the millions of Americans with severe, sometimes-fatal allergic reactions to food.

After 16 weeks on Xolair , two-thirds of participants allergic to peanuts and at least two other foods (such as milk and eggs) were able to eat the equivalent of two and a half peanuts.

This study persuaded the FDA to approve the drug for food allergies.

Patients with only mild allergies might not find an injection every two or four weeks worth the trouble.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive